Concentrix (NASDAQ:CNXC) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Concentrix (NASDAQ:CNXC) from a hold rating to a buy rating in a report issued on Saturday.

CNXC has been the topic of several other research reports. Robert W. Baird set a $52.00 target price on Concentrix in a research note on Wednesday, January 14th. Barrington Research reaffirmed an “outperform” rating and set a $62.00 price objective on shares of Concentrix in a research report on Monday, January 12th. Finally, Weiss Ratings lowered shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $63.75.

Concentrix Trading Up 0.5%

NASDAQ CNXC opened at $30.39 on Friday. The firm’s 50 day moving average price is $40.00 and its two-hundred day moving average price is $43.50. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.40 and a current ratio of 1.40. Concentrix has a twelve month low of $29.35 and a twelve month high of $66.00. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of -1.46, a PEG ratio of 0.32 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last released its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The company had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.54 billion. During the same quarter in the prior year, the company earned $3.26 earnings per share. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Equities analysts anticipate that Concentrix will post 10.11 EPS for the current year.

Concentrix Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 10th. Shareholders of record on Friday, January 30th were given a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend was Friday, January 30th. Concentrix’s payout ratio is currently -6.91%.

Insider Activity at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of the company’s stock in a transaction dated Thursday, January 29th. The shares were bought at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the purchase, the chief executive officer directly owned 362,075 shares in the company, valued at $13,422,120.25. This trade represents a 0.28% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Concentrix

Large investors have recently bought and sold shares of the business. AQR Capital Management LLC boosted its position in Concentrix by 25.5% during the second quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock worth $226,252,000 after purchasing an additional 875,556 shares during the period. Pzena Investment Management LLC raised its position in shares of Concentrix by 32.3% in the fourth quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock valued at $121,713,000 after purchasing an additional 714,604 shares during the period. Deprince Race & Zollo Inc. acquired a new stake in shares of Concentrix in the third quarter worth $31,768,000. Dimensional Fund Advisors LP boosted its holdings in shares of Concentrix by 28.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after buying an additional 551,778 shares during the period. Finally, Alyeska Investment Group L.P. acquired a new position in Concentrix in the 4th quarter valued at $22,913,000. 90.34% of the stock is currently owned by institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.